104 related articles for article (PubMed ID: 35174936)
1. TRIM39 is a poor prognostic factor for patients with estrogen receptor-positive breast cancer and promotes cell cycle progression.
Ogura T; Azuma K; Takeiwa T; Sato J; Kinowaki K; Ikeda K; Kawabata H; Inoue S
Pathol Int; 2022 Feb; 72(2):96-106. PubMed ID: 35174936
[TBL] [Abstract][Full Text] [Related]
2. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
Ogura T; Azuma K; Sato J; Kinowaki K; Takayama KI; Takeiwa T; Kawabata H; Inoue S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768935
[TBL] [Abstract][Full Text] [Related]
3. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
4. TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21.
Zhang L; Mei Y; Fu NY; Guan L; Xie W; Liu HH; Yu CD; Yin Z; Yu VC; You H
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20937-42. PubMed ID: 23213251
[TBL] [Abstract][Full Text] [Related]
5. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo.
Chiang KC; Chen HY; Hsu SY; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Sun CC; Lee JM; Yeh CN; Juang HH
Drug Des Devel Ther; 2015; 9():4631-8. PubMed ID: 26316702
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitylation of p53 by the APC/C inhibitor Trim39.
Zhang L; Huang NJ; Chen C; Tang W; Kornbluth S
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20931-6. PubMed ID: 23213260
[TBL] [Abstract][Full Text] [Related]
7. TRIM39 deficiency inhibits tumor progression and autophagic flux in colorectal cancer via suppressing the activity of Rab7.
Hu J; Ding X; Tian S; Chu Y; Liu Z; Li Y; Li X; Wang G; Wang L; Wang Z
Cell Death Dis; 2021 Apr; 12(4):391. PubMed ID: 33846303
[TBL] [Abstract][Full Text] [Related]
8. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
9. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
10.
Fang Z; Wang Y; Wang Z; Xu M; Ren S; Yang D; Hong M; Xie W
Cancer Res; 2020 Oct; 80(20):4399-4413. PubMed ID: 32826278
[TBL] [Abstract][Full Text] [Related]
11. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C; Benz CC
Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
14. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Clin Breast Cancer; 2021 Oct; 21(5):399-407.e2. PubMed ID: 33386231
[TBL] [Abstract][Full Text] [Related]
15. Fish TRIM39 regulates cell cycle progression and exerts its antiviral function against iridovirus and nodavirus.
Wang W; Huang Y; Yu Y; Yang Y; Xu M; Chen X; Ni S; Qin Q; Huang X
Fish Shellfish Immunol; 2016 Mar; 50():1-10. PubMed ID: 26784918
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
18. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
